Troxerutin-carbazochrome combination versus placebo in the treatment of posthemorrhoidectomy symptoms: A single-center, randomized, double-blind, placebo-controlled study

Current Therapeutic Research - Clinical and Experimental

Volumn 63, Issue 9, 2002, Pages 527-535

  Basile, Marco ^a   Gidaro, Stefano ^a   Pacella, Massimo ^a   Biffignandi, Paolo M ^b   Gidaro, Giacomo S ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b Soc Italiana Attivita Farmaceutiche   (Italy)

Author keywords

Carbazochrome; Flavonoids; Hemorrhoid; Troxerutin

Indexed keywords

ADRENALIN; ANALGESIC AGENT; CARBAZOCHROME; FLAVONOID; PLACEBO; TROXERUTIN;

ADULT; ANALGESIA; ARTICLE; BLEEDING; BLOOD CLOTTING TEST; CHRONIC VEIN INSUFFICIENCY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFECATION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; ERYTHEMA; FEMALE; FUNCTIONAL ASSESSMENT; HEADACHE; HEMORRHOID; HEMORRHOIDECTOMY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OXIDATION; PAIN; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT PLANNING; VERTIGO; VISUAL ANALOG SCALE;

EID: 0036747527     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(02)80058-3     Document Type: Article

References (15)

1. Ahmed SK, Thompson HJ. The effect of breakfast on minor anal complaints: A matched case-control study. J R Coll Surg Edinburgh. 1997;42:331-333.
2. Brisinda G. How to treat haemorrhoids. Prevention is best; Haemorrhoidectomy needs skilled operators. BMJ. 2000;321:582-583.
3. Wadworth AN, Faulds D. Hydroxyethylrutos ides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders. Drugs. 1992;44: 1013-1032.
4. Wenisch C, Biffignandi PM. Effect of bioflavonoids (trihydroxyethylrutin and disodium flavodate) in vitro on neutrophil reactive oxygen production and phagocytic ability assessed by flow cytometry. Curr Med Res Opin. 2001;17:123-127.
5. Radtke H, Kiesewetter H, Schneider R. The rheological properties of cumarine and troxerutin [in German]. Therapiewoche Schweiz. 1983;49:6662-6666.
6. Boada JN, Nazco GJ. Therapeutic effect of venotonics in chronic venous insufficiency: A meta-analysis. Clin Drug Invest. 1999;18:413-432.
7. MacLennan WJ, Wilson J, Rattenhuber V, et al. Hydroxyethylrutosides in elderly patients with chronic venous insufficiency: Its efficacy and tolerability. Gerontology. 1994;40:45-52.
8. Frick RW. Three treatments for chronic venous insufficiency: Escin, hydroxyethylrutoside, and Daflon. Angiology. 2000;51:197-205.
9. Carlsson K, Patwardhan A, Poullain JC, Gerentes I. Transport and localization of troxerutin in the venous wall [in French]. J Mal Vasc. 1996;21(Suppl C):270-274.
10. Boisseau MR, Taccoen A, Garreau C, et al. Fibrinolysis and hemorheology in chronic venous insufficiency: A double blind study of troxerutin efficiency. J Cardiovasc Surg (Torino). 1995;36:369-374.
11. Basile M, Gidaro S, Pacella M, et al. Parenteral troxerutin and carbazochrome combination in the treatment of post-hemorrhoidectomy status: A randomized, double-blind, placebo-controlled, phase IV study. Curr Med Res Opin. 2001;17:256-261.
12. Singer AJ, Thode HC Jr. Determination of the minimal clinically significant difference on a patient visual analog satisfaction scale. Acad Emerg Med. 1998;5:1007-1011.
13. Roland IH, Bougelet C, Ninane N, et al. Effect of hydroxyethylrutosides on hypoxial-induced neutrophil adherence to umbilical vein endothelium. Cardiovasc Drugs Ther. 1998;12:375-381.
14. van Acker FA, van Acker SA, Kramer K, et al. 7-Monohydroxyethylrutoside protects against chronic doxorubicin-induced cardiotoxicity when administered only once per week. Clin Cancer Res. 2000;6:1337-1341.
15. Squadrito F, Altavilla D, Oliaro Bosso S. Double-blind, randomized clinical trial of troxerutin-carbazochrome in patients with hemorrhoids. Eur Rev Med Pharmacol Sci. 2000;4:21-24.